Traumatic brain injury (TBI) accounts for approximately 10 million deaths and/or hospitalizations annually in the world, and approximately 1.5 million annual emergency room visits and hospitalizations in the US. TBI can cause cell death, excitotoxicity, neuroinflammation, cerebrovascular breakdown, behavioral deficits, such as learning and memory, neurological motor impairments, post-traumatic convulsions, or seizures.
There is growing evidence that some of the symptoms of TBI respond to the endocannabinoid system part in the brain's repair mechanism. The endocannabinoid system is one of the major homeostatic regulatory systems of the body which has potential for the treatment of diverse TBI symptoms through its antioxidant and anti-inflammatory effects.
While cannabis medicine is not a panacea, many medical cannabis patients are using cannabis as adjunctive treatments along with prescribed pharmaceutical drugs or in some cases replacing the pharma drugs with cannabis products to mitigate the symptoms of TBI.
According to TraumaticBrainInjury.com - a disability community service for TBI survivors - these are the highest causes of brain injury: Open head injury, closed head injury, deceleration injuries, chemical/toxic, hypoxia, tumors, infections, and stroke. Traumatic brain injury also results from penetrating wounds, severe blows to the head with shrapnel or debris, and falls or bodily collisions with objects following a blast.
In a paper published by Dr. Ethan Russo in 2017, he reviewed the research on how components of cannabis, THC, CBD, and the terpenoids linalool, limonene, alpha-pinene, and other phytocannabinoids may provide multiple benefits to target symptoms of neurological and psychological disorders.
Please join us Wednesday, January 27, 6-7:30 PM for our FREE monthly zoom educational talk. We will review this research and discuss the cannabis products being recommended by the researchers and TBI patients.
Click the link to register for the zoom talk on our Cannabis Patients PNW website.
댓글